Yumiko Tsushima, Betul Hatipoglu
OBJECTIVE: To review evidence of existing literature on the management of statin intolerance. METHODS: We searched for literature pertaining to statin intolerance and treatments in PubMed. We reviewed articles published between 2005 and 2022. RESULTS: Statin-associated myalgia is the most common adverse effect of statin therapy and the most common reason for statin discontinuation. Risk factors for statin intolerance include unexplained muscle pain with other lipid-lowering therapy, unexplained cramps, history of elevated creatinine kinase levels, family history of muscle symptoms, and family history of muscle symptoms with lipid therapy...
March 21, 2023: Endocrine Practice
Daniel I Bisno, Sara Lubitz, Ian Marshall, David A Cohen
OBJECTIVE: The World Professional Association for Transgender Health (WPATH) Standards of Care (SOC) Version 7 recommended that before initiating gender-affirming hormone therapy (GAHT), patients should seek a psychosocial evaluation from a mental health professional documenting a diagnosis of persistent gender dysphoria. The Endocrine Society published guidelines in 2017 recommending against an obligatory psychosocial evaluation, which was affirmed in the recently published WPATH SOC Version 8 from 2022...
March 9, 2023: Endocrine Practice
Sawsan Kurdi, Ahmad Alamer, Haytham Wali, Aisha F Badr, Merri L Pendergrass, Nehad Ahmed, Ivo Abraham, Maryam T Fazel
OBJECTIVE: Using supervised machine learning algorithms (SMLAs), we built models to predict the probability of type 1 diabetes mellitus (T1DM) patients on insulin pump therapy for meeting insulin pump self-management behavioral (IPSMB) criteria and achieving good glycemic response within six months. METHODS: This was a single-center retrospective chart review of 100 adult T1DM patients on insulin pump therapy (>6 months). Three SMLAs were deployed: multivariable logistic regression (LR), random forest (RF), and K-nearest neighbor (k-NN); validated using repeated three-fold cross-validation...
March 8, 2023: Endocrine Practice
Richard J Robbins, Trisha D Cubb, Maleeha Zahid, Jiaqiong Xu
OBJECTIVE: Detection of residual differentiated thyroid cancer is important but difficult. A variety of imaging modalities and biochemical markers have been used with moderately good success. We hypothesized that elevated perioperative serum anti-thyroglobulin antibodies (TgAb) would also be a predictive marker for persistent or recurrent thyroid cancer. METHODS: We performed a retrospective analysis of 277 differentiated thyroid cancer survivors divided into two groups: those with low or normal serum TgAb (TgAb-) and those with elevated serum TgAb (TgAb+)...
March 6, 2023: Endocrine Practice
Petra Buzkova, Jane A Cauley, Howard A Fink, John A Robbins, Kenneth J Mukamal, Joshua I Barzilay
OBJECTIVES: Advancing age is a powerful risk factor for hip fracture. The biological mechanisms through which aging impacts hip fracture risk have not been well studied. METHODS: Biological factors associated with "advancing age" that help to explain how aging is associated with hip fracture risk are reviewed. The findings are based on analyses of the Cardiovascular Health Study, an ongoing observational study of adults ages >65 years with 25 years of follow up...
March 6, 2023: Endocrine Practice
Lena Chu, Sarah Gold, Carlyn Harris, Leslie Lawley, Pranav Gupta, Vin Tangpricha, Michael Goodman, Howa Yeung
OBJECTIVE: This retrospective cohort study aimed to assess incidence and predictors of acne among transgender adolescents receiving testosterone. MATERIALS AND METHODS: We analyzed records of patients aged <18 years, assigned female at birth seen at Children's Healthcare of Atlanta Pediatric Endocrinology clinic for testosterone initiation between 1/1/2000-1/1/2019, with at least 1-year follow-up documented. Bivariable analyses to determine association of clinical and demographic factors with new acne diagnosis were calculated...
March 6, 2023: Endocrine Practice
Koen M A Dreijerink
No abstract text is available yet for this article.
March 4, 2023: Endocrine Practice
Justine S Herndon, Arvind K Maheshwari, Todd B Nippoldt, Sara J Carlson, Caroline J Davidge-Pitts, Alice Y Chang
OBJECTIVE: Gender-affirming hormone therapy (GAHT) guidelines describe estradiol doses for intramuscular (IM), but not subcutaneous (SC) routes. Objective was to compare SC and IM estradiol doses and hormone concentrations in transgender and gender diverse (TGD) individuals. METHODS: Retrospective cohort study at a single site tertiary care referral center. Patients were TGD individuals receiving injectable estradiol with at least 2 estradiol measurements. Main outcomes were median doses and achieved serum hormone concentrations between SC and IM routes...
March 1, 2023: Endocrine Practice
Rossy S López-Prieto, Alfredo A Reza-Albarrán, Patricia Clark, Rita A Gómez Díaz, Miguel S Aguilera-Ruvalcaba, Diana C Güereca-Olguín, Grecia Q Jalife-Velázquez, Adrián Soto-Mota, Tannia L Viveros-Ruiz, Liliana Juárez-Martínez, Francisco J Gómez-Pérez, Paloma Almeda-Valdes
OBJECTIVE: Studies have found a significant decrease in bone mineral density (BMD) in individuals with type 1 diabetes (T1D) compared to healthy controls. Factors associated with this phenomenon have yet to be defined; therefore, this study aimed to explore the association of glycated hemoglobin (HbA1c), disease duration, albuminuria, and glomerular filtration rate (GFR) with BMD in adults with T1D. METHODS: Cross-sectional study carried out in tertiary care. BMD analysis was performed by dual X-ray absorptiometry (DXA)...
February 22, 2023: Endocrine Practice
Ping Peng, Neng Zhang, Jingjing Huang, Xiaojuan Jiao, Yunfeng Shen
OBJECTIVE: Wearable activity monitors are promising tools for improving metabolic outcomes in patients with type 2 diabetes mellitus (T2DM), but no uniform conclusive evidence is available. The study aimed to evaluate the effects of intervention using wearable activity monitors on blood glucose, blood pressure, blood lipid, weight, waist circumference and body mass index (BMI) in T2DM. METHODS: Two independent reviewers searched four online databases (PubMed, the Cochrane Library, Web of Science and Embase) to identify relevant studies published from January 2000 to October 2022...
February 17, 2023: Endocrine Practice
Nipith Charoenngam, Thanitsara Rittiphairoj, Ben Ponvilawan, Aunchalee Jaroenlapnopparat, Palapun Waitayangkoon, Pichatorn Suppakitjanusant, Vitchapong Prasitsumrit, Chatlert Pongchaiyakul, Michael F Holick
OBJECTIVE: To investigate bone fragility in patients with hereditary connective tissue disorders (HCTD), including Ehlers-Danlos syndrome (EDS), Marfan's syndrome (MFS) and Loeys-Dietz syndrome (LDS). METHODS: From inception to June 2022, potentially eligible studies were identified in the Medline and EMBASE databases using search strategy that included terms for "HCTD", "Fracture" and "Osteoporosis". Eligible studies must consist of a group of patients with HCTD and report prevalence/incidence of fracture/osteoporosis in their participants, with or without comparison with healthy individuals...
February 17, 2023: Endocrine Practice
Farah Morgan, Krystal Hunter
No abstract text is available yet for this article.
February 3, 2023: Endocrine Practice
Julia R Donner, Phinnara Has, Lisa Swartz Topor
OBJECTIVE: Graves disease (GD), an autoimmune disease of the thyroid, is likely caused by a combination of genetic predisposition and environmental triggers. Recent data suggests that Coronavirus-19 disease may be associated with development of autoimmune disease. The aim of this study was to assess the incidence and characteristics of new GD diagnoses in youth prior to and during the COVID-19 pandemic. METHODS: We performed a retrospective chart review of all new GD diagnoses in patients 0-18 years of age diagnosed at a tertiary care pediatric hospital between 1/1/2018-12/31/21...
January 31, 2023: Endocrine Practice
Kerstin Ekbom, Svetlana Lajic, Henrik Falhammar, Anna Nordenström
OBJECTIVE: Congenital adrenal hyperplasia (CAH) refers to a group of genetic disorders that affect cortisol biosynthesis and the need for glucocorticoid treatment is lifelong. The complexities of CAH can greatly affect teenage life and the transition from pediatric to adult care. The aim was to assess transition readiness and the impact on quality of life (QoL) as well as medication adherence rates in adolescents and young adults with CAH. METHODS: Prospective assessment of transition readiness was conducted through standardized questionnaires for adolescents and young adults (aged 16-35)...
January 21, 2023: Endocrine Practice
Ana-Maria Chindris, Kaniksha Desai, Selmin Karatayli Ozgursoy, Michael G Heckman, John D Casler
OBJECTIVE: To determine the effect of a 4 hour postoperative serum parathyroid hormone (PTH) guided calcium and calcitriol supplementation protocol on the incidence of hypocalcemia and hospital readmissions in patients undergoing total thyroidectomy. METHODS: This was a single institution, retrospective chart review of patients who underwent total thyroidectomy, 148 had been operated on prior to the protocol implementation and 389 after. Hypocalcemia risk was stratified as low (PTH >30 pg/ml), medium (15-30 pg/ml), and high (<15 pg/ml), using serum PTH values obtained 4 hours postoperatively...
January 19, 2023: Endocrine Practice
Po-Chih Chen, Chien-Tai Hong, Wan-Ting Chen, Lung Chan, Li-Nien Chien
OBJECTIVE: Metformin is widely used as the first-line drug for type II diabetes mellitus (T2DM), and has numerous benefits apart from lowering blood glucose. However, metformin-retained regimen is challenged by newly launching, powerful glucose-lowering antiglycemic agents. This population-based cohort study examined the association between metformin adherence and the risk of dementia and Parkinson's disease (PD). METHODS: Diabetic patients with metformin-included combination antiglycemic therapy were identified from the National Health Insurance Research Database and categorized into metformin-adherent and -nonadherent groups according to the medical record of the first year prescription...
January 16, 2023: Endocrine Practice
Fereidoun Azizi, Hengameh Abdi, Ladan Mehran, Petros Perros, Safdar Masoumi, Atieh Amouzegar
OBJECTIVE: The aim of this study was to compare long-term outcomes in terms of new onset or worsening of GO in patients with Graves' disease treated with different therapeutic modalities for hyperthyroidism. METHODS: A total of 1163 patients with Graves' disease entered this study; 263 patients were treated with radioiodine and 808 patients received MMI therapy for a median of 18 months of whom, 178 patients continued MMI for a total of 96 months (long-term MMI)...
January 14, 2023: Endocrine Practice
Xiaohong Lyu, Yuelun Zhang, Dingyue Zhang, Huijuan Zhu, Hui Pan, Shi Chen, Lin Lu
OBJECTIVE: Previous studies have shown inconsistent results about the usefulness of prolactin adjustment in bilateral inferior petrosal sinus sampling (BIPSS) in the differential diagnosis of adrenocorticotropic hormone (ACTH) -dependent Cushing syndrome (CS). This meta-analysis compared the diagnostic accuracy of prolactin adjustment vs. no adjustment in BIPSS. METHODS: This study searched PubMed, Embase, Web of Science, Cochrane library, and Wanfang database for published data on the use of prolactin adjustment in BIPSS to differentially diagnose ACTH-dependent CS as of March 2022...
January 14, 2023: Endocrine Practice
Hayder A Hasan, Thomas M Barber, Samer Cheaib, Ayla Coussa
OBJECTIVES: Vitamin D deficiency impairs female fertility and the success of in vitro fertilization (IVF). The recommended serum 25-hydroxy vitamin D (25(OH)D) level in IVF-conceived pregnancies is still debated. We aimed to explore the relationship of preconception serum 25(OH)D level with pregnancy outcome following IVF treatment. We also explored the utility of the currently recommended serum 25(OH)D cut-off of ≥50 nmol/L for women undergoing IVF therapy. METHODS: Retrospective cohort of women who had undergone IVF therapy...
January 12, 2023: Endocrine Practice
Sajid Iqbal, Abdulrahim Abu Jayyab, Ayah Mohammad Alrashdi, Silvia Reverté-Villarroya
OBJECTIVE: This systematic review and meta-analysis aimed to investigate the predictive ability of plasma connecting peptide (C-peptide) levels in discriminating type 1 diabetes (T1D) from type 2 diabetes (T2D) and to inform evidence-based guidelines in diabetes classification. METHODS: We conducted a holistic review and meta-analysis using PubMed, MEDLINE, EMBASE, and Scopus. The citations were screened from 1942 to 2021. The quality criteria and the preferred reporting items for systematic reviews and meta-analysis checklist were applied...
January 11, 2023: Endocrine Practice
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read

Save your favorite articles in one place with a free QxMD account.


Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.